BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/6/2019 5:44:00 PM | Browse: 71 | Download: 77
Publication Name World Journal of Clinical Cases
Manuscript ID 47026
Country of Manuscript Source Taiwan
Received
2019-03-04 06:11
Peer-Review Started
2019-03-04 08:03
To Make the First Decision
2019-04-02 02:57
Return for Revision
2019-04-03 00:32
Revised
2019-04-14 15:38
Second Decision
2019-04-18 10:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-04-19 01:45
Articles in Press
2019-04-19 01:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
2019-04-30 19:25
Typeset the Manuscript
2019-06-05 09:53
Publish the Manuscript Online
2019-06-06 17:44
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Medicine, Research and Experimental
Manuscript type Retrospective Cohort Study
Article Title Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals
Manuscript Source Unsolicited Manuscript
All Author List Yi-Chun Chen, Chung-Yi Li, Shiang-Jiun Tsai and Yen-Chun Chen
ORCID
Author(s) ORCID Number
Yi-Chun Chen http://orcid.org/0000-0003-2153-272X
Chung-Yi Li http://orcid.org/0000-0002-0321-8908
Shiang-Jiun Tsai http://orcid.org/0000-0002-0644-8223
Yen-Chun Chen http://orcid.org/0000-0002-9739-9905
Funding Agency and Grant Number
Funding Agency Grant Number
Dalin Tzu Chi Hospital DTCRD 104-I-16
Corresponding author Yi-Chun Chen, MD, Assistant Professor, Doctor, Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No. 2, Minsheng Rd., Dalin Township, Chiayi County 622, Taiwan. chenyichun0320@yahoo.com.tw
Keywords Hepatitis C virus; Chronic kidney disease; End-stage renal disease; Anti-hepatitis C virus therapy; Cohort study
Core Tip This large nationwide retrospective cohort study used propensity score-matched and competing risk analyses to evaluate the long-term hard endpoints of hepatitis C virus (HCV) infection and anti-HCV therapy, especially interferon-based therapy, in chronic kidney disease (CKD) patients. We found that untreated HCV infection in CKD was associated with increased risks of end-stage renal disease and mortality. On the contrary, adequate anti-HCV therapy in CKD patients improves long-term renal and patient survivals.
Publish Date 2019-06-06 17:44
Citation Chen YC, Li CY, Tsai SJ, Chen YC. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals. World J Clin Cases 2019; 7(11): 1270-1281
Url URL: https://www.wjgnet.com/2307-8960/full/v7/i11/1270.htm
DOI DOI: https://dx.doi.org/10.12998/wjcc.v7.i11.1270
Full Article (PDF) WJCC-7-1270.pdf
Full Article (Word) WJCC-7-1270.docx
Manuscript File FP6825_de16_CE1MS_edit2.docx
Answering Reviewers 47026-Answering reviewers.pdf
Audio Core Tip 47026-Audio core tip.mp3
Biostatistics Review Certificate 47026-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 47026-Conflict-of-interest statement.pdf
Copyright License Agreement 47026-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 47026-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 47026-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 47026-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 47026-Language certificate.pdf
Supplementary Material 47026-Supplementary material.doc
Peer-review Report 47026-Peer-review(s).pdf
Scientific Misconduct Check 47026-Scientific misconduct check.pdf
Scientific Editor Work List 47026-Scientific editor work list.pdf